Neurocrine Biosciences (NBIX) Interest Expenses (2017 - 2021)
Historic Interest Expenses for Neurocrine Biosciences (NBIX) over the last 5 years, with Q3 2021 value amounting to $6.6 million.
- Neurocrine Biosciences' Interest Expenses fell 2235.29% to $6.6 million in Q3 2021 from the same period last year, while for Dec 2021 it was $19.2 million, marking a year-over-year decrease of 2320.0%. This contributed to the annual value of $32.0 million for FY2019, which is 469.37% up from last year.
- According to the latest figures from Q3 2021, Neurocrine Biosciences' Interest Expenses is $6.6 million, which was down 2235.29% from $6.2 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Interest Expenses ranged from a high of $8.5 million in Q3 2020 and a low of $4.8 million during Q2 2017
- For the 5-year period, Neurocrine Biosciences' Interest Expenses averaged around $7.4 million, with its median value being $7.7 million (2018).
- Its Interest Expenses has fluctuated over the past 5 years, first surged by 5924.06% in 2018, then plummeted by 2530.12% in 2021.
- Quarter analysis of 5 years shows Neurocrine Biosciences' Interest Expenses stood at $7.4 million in 2017, then grew by 4.64% to $7.8 million in 2018, then increased by 5.15% to $8.2 million in 2019, then rose by 4.13% to $8.5 million in 2020, then dropped by 22.35% to $6.6 million in 2021.
- Its Interest Expenses stands at $6.6 million for Q3 2021, versus $6.2 million for Q2 2021 and $6.4 million for Q1 2021.